Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Biotechnology Separation Systems Companies, Market Entry and Expansion Strategies

Date : 25 March 2026

Top Vendors in the Biotechnology Separation Systems Market & Their Offerings

Biotechnology Separation Systems Market Companies are Danaher, Thermo Fisher Scientific, BD, Merck KGaA, GE Healthcare, Agilent Technologies, Sysmex Corporation

Everything you need to know about the Biotechnology Separation Systems Market: Access the Dashboard

Companies Headquarters Offerings
Danaher Washington, U.S. Offers chromatography resins, filtration systems, and integrated bioprocessing platforms supporting large-scale biologics manufacturing and purification processes.
Thermo Fisher Scientific   Massachusetts, U.S. Provides advanced purification technologies, membrane filtration systems, and analytical instruments for efficient biotech separation and drug development workflows.
BD New Jersey, U.S. Specializes in flow cytometry, cell sorting, and sample preparation systems for cell-based separation and research applications.
Merck KGaA Darmstadt, Germany Delivers chromatography columns, filtration units, and single-use technologies for scalable and high-purity biopharmaceutical separation processes.
GE Healthcare  Chicago, U.S. Offers bioprocessing equipment, chromatography systems, and purification solutions widely used in biologics production and downstream processing.
Agilent Technologies California, U.S. Provides HPLC systems, chromatography columns, and sample preparation tools for precise separation and analytical testing in biotech applications.
Sysmex Corporation Kobe, Japan Offers advanced cell analysis, hematology systems, and separation technologies supporting clinical diagnostics and laboratory research. 
Alfa Wassermann  New Jersey, U.S. Focuses on centrifugation equipment and sample separation systems used in clinical, research, and biotechnology laboratories.
Shimadzu Corporation Kyoto, Japan provides LC/GC systems, chromatography solutions, and analytical instruments for high-precision separation and quality analysis in biotech industries.

Supply Chain Analysis

Clinical Trials

  • Clinical trials in biotechnology separation systems mainly aim to assess the safety, effectiveness, and scalability of techniques such as chromatography, membrane filtration, and cell sorting. These studies ensure that separation processes meet quality standards for drug manufacturing and therapeutic use. They also help optimize purification efficiency and regulatory compliance.
  • Key players: Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, and Sartorius AG.

Regulatory Approvals

  • Regulatory approvals for biotechnology separation systems are complex and strictly enforced to ensure the purity, safety, and effectiveness of biologics such as vaccines, proteins, and monoclonal antibodies. Techniques like chromatography, filtration, centrifugation, and flow cytometry must meet standards set by agencies like the U.S. Food and Drug Administration, European Medicines Agency, and World Health Organization.
  • Key players: GE HealthCare, Thermo Fisher Scientific, Merck KGaA, and Agilent Technologies.

Patient Support and Services

  • Patient support and service offerings in biotechnology separation systems focus on improving process efficiency, reducing operational costs, and maintaining regulatory compliance in biopharmaceutical manufacturing. These services include system installation, maintenance, user training, and audit support, especially for chromatography, filtration, and centrifugation technologies.
  • Key players: Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, and Merck KGaA.

Market Growth

The global biotechnology separation systems market size was estimated at USD 14.06 billion in 2025 and is predicted to increase from USD 15.86 billion in 2026 to approximately USD 46.89 billion by 2035, expanding at a CAGR of 12.8% from 2026 to 2035.

Biotechnology Separation Systems Market Size is USD 15.86 Billion in 2026.

What are the Recent Developments in the Biotechnology Separation Systems Market?

  • In September 2025, Sysmex Corporation introduced next-generation cell analysis technologies to support clinical and research separation needs.
  • In June 2025, Agilent Technologies enhanced its liquid chromatography platforms with improved sensitivity for complex biologic sample analysis.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales